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OBJECTIVES We assessed the use of intracardiac echocardiography (ICE) as the primary means for both
selection of the Amplatzer Septal Occluder (ASO) and the guidance of transcatheter closure
of secundum atrial septal defects (ASDs).
BACKGROUND The standard method for transcatheter closure of ASDs requires balloon-sizing maneuver and
transesophageal echocardiographic (TEE) monitoring. The role of ICE during transcatheter
closure of ASDs has not yet been established.
METHODS In 91 patients with ASDs, two standardized orthogonal sections were used to obtain ICE-derived
measurements of the fossa ovalis and to assess optimal device deployment: the transverse section
on the aortic valve plane, and the longitudinal section on the four-chamber plane.
RESULTS In all patients, ICE planes were identified with excellent resolution, providing proper
measurements of the fossa ovalis, from which to derive geometric assumptions for the
selection of an appropriately sized device. The ASO waist diameter was chosen on the basis
of the r value (rc2  p2, where r is the radius of an ideal circle that intersects the elliptical
fossa ovalis in its semi-latus rectum, c is the foci half-distance of the fossa ovalis, and p is its
semi-latus rectum). During the procedure, the four-chamber plane allowed us to obtain easily
interpretable images of all stages of device deployment. Midterm complete occlusion rate was
97.8%. No ICE-related complications occurred.
CONCLUSIONS The ICE evaluation of ASDs allows quantitative and qualitative information for both proper
ASO selection and optimal device placement, thus eliminating the cumbersome balloon-
sizing maneuver and the need for general anesthesia during TEE monitoring. (J Am Coll
Cardiol 2003;42:1677–82) © 2003 by the American College of Cardiology Foundation
The universally accepted and most frequently used methods
for Amplatzer Septal Occluder (ASO) device selection and
deployment include balloon-sizing maneuver (1,2) and
transesophageal echocardiography (TEE) monitoring (3,4).
However, both of these methods have their drawbacks. On
the one hand, balloon-sizing is a blind technique that
cannot provide delineation on site, on shape, and on the
dynamic geometry of the secundum atrial septal defect
(ASD), or provide information on characteristics of the
surrounding structures; moreover, it can be somewhat inac-
curate, sometimes causing oversizing or undersizing of the
device (5). On the other hand, TEE is a technique that may
not be indicated in all patients in which the majority
requires general anaesthesia with or without endotracheal
intubation, owing to the poor acceptance of an esophageal
probe for the entire duration of the procedure; furthermore,
the risks of aspiration, airway obstruction, esophageal per-
foration, and vocal cord dysfunction have been reported,
although infrequently (6,7).
Over the past several years, intracardiac echocardiography
(ICE) has been used in the descriptive evaluation of the
atrial structures to facilitate trans-septal puncture (8,9), to
guide radiofrequency ablation lesions (10–12), and to pro-
vide a practical approach for precise determination of left
ventricular function (13) and aortic valve area (14). On the
basis of these previous studies, investigators explored, in an
in vitro model, the possibility of an accurate and reliable
evaluation of the size of ASDs by ICE (15). More recently,
interventional cardiologists have performed ICE using both
electronic multi-element (16) and mechanical single-
element (17) systems in the cardiac catheterization labora-
tory during transcatheter closure of ASDs, finding a signif-
icant correlation between ICE and the other conventional
methods; however, the definitive confirmation of ASO
selection was based on the balloon-sizing technique.
This study describes the use of ICE alone to monitor and
guide transcatheter closure of ASDs using ASO, thus
eliminating the cumbersome balloon-sizing maneuver and
the need for general anesthesia or deep sedation during
TEE monitoring.
METHODS
Study patients. Between July 2000 and November 2001, a
total of 91 consecutive eligible patients with hemodynami-
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cally significant ASDs (34 male and 57 female; mean age
49.2  14.8 years, range 15 to 73 years) underwent
transcatheter closure using the ASO (AGA Medical Corp.,
Golden Valley, Minnesota) under fluoroscopy and ICE
guidance without use of the balloon-sizing maneuver. A full
description of the device has been reported previously
(3,4,18). The local ethical committee approved the protocol,
and written informed consent was obtained from all patients
or their respective guardians.
ICE. The ICE was performed by the same interventional
team (single operator use) using a commercially available
9F–9MHz Ultra ICE catheter-based ultrasound transducer
(EP Technologies, Boston Scientific Corp., San Jose, Cal-
ifornia), as previously described (19). The axial and the
lateral resolutions were 0.27 mm and 0.26 mm, respectively,
whereas the radial imaging depth of penetration was about
5 cm.
The Ultra ICE catheter was introduced percutaneously
into the left femoral vein through a 55° precurved polyeth-
ylene long venous sheath (Convoy, EP Technologies, Bos-
ton Scientific Corp.). Two standardized orthogonal sections
were used to obtain ICE-derived fossa ovalis measurements
and to assess optimal device deployment: the transverse
section on the aortic valve plane in the short-axis of the
body, and the longitudinal section on the four-chamber
plane in the long-axis of the heart. The latter view was also
used to monitor all stages of the device deployment.
The transverse section was obtained with the precurved
sheath withdrawn to the infrarenal portion of the inferior
vena cava and the Ultra ICE catheter neutrally positioned
under fluoroscopic guidance in the body of the right atrium,
with the transducer at the level of 6° to 7° intervertebral
thoracic disk, to transversally scan the atrial septum on the
aortic valve plane. By convention (19), this image was
electronically rotated and presented in a consistent and
familiar orientation identical to that of a magnetic resonance
imaging format, with left-sided structures on the operator’s
right, anterior-sided structures at the top of the image, and
so forth.
The longitudinal section was obtained with the 55°
precurved introducer sheath advanced up to the end of the
catheter and turned posterior and leftward astride the defect
under fluoroscopic guidance so as to scan the atrial septum
in its long-axis. The resultant image replicated the apex-up
four-chamber TEE and magnetic resonance views, without
the need for image reorientation. Real-time cross-sectional
images (30 frames/s) were recorded on super-VHS video-
tapes for off-line archiving and review.
The major (2a) and the minor (2b) axes of the fossa ovalis
(i.e., septum secundum-to-septum secundum distance) on
these two orthogonal planes were measured by two blind
observers, using end-diastolic frames. By assuming its shape
to be an ideal ellipse (Fig. 1), we calculated the following
data (Appendix): the ellipse eccentricity (e 
a2  b2
a ,
where e may be defined as the ratio of the distance from the
center to a focus and the distance from the center to an end
point of the major axis), the foci half-distance
c  a2  b2, where c may be defined as the half-distance
between the two points called foci, the sum of whose
distances from any point on the ellipse is constant), the
semi-latus rectum distance (p
b2
a , where p may be defined as
the chord through a focus parallel to the directrix of the
ellipse), and the ellipse perimeter (PFO) and area (AFO).
From these data, we calculated the radius of an ideal circle
(Fig. 2) that intersects the elliptical fossa ovalis in its
semi-latus rectum (r), the circumference (CASO) and area
(AASO) of this ideal circle, whose values are equal to that of
the waist of the implanted ASO. This ideal-derived circle is
the only one that might be in a constant and repetitive
manner determined for any given ellipse, and it is the one
that may best fit the elliptical shape of ASDs because its
circumference and area are equal to the same approximate
precision to the ellipse perimeter and area. In fact, the size
of the waist of the ASO was chosen exclusively on the basis
of the r value, speculating that coexistent septum primum
tissue within the fossa ovalis could not adequately support
the device, whereas the radial force of its waist could easily
distend it.
Before and after the release of the prosthesis, its correct
positioning was judged in the two orthogonal sections using
qualitative ICE criteria, such as coverage of the entire fossa
Abbreviations and Acronyms
ASD  secundum atrial septal defect
ASO  Amplatzer Septal Occluder
ECG electrocardiography
ICE  intracardiac echocardiography
TEE  transesophageal echocardiography
Figure 1. Geometry of an ellipse. In our example here, the ellipse is longer
in the horizontal direction: this length is called the major axis and the
up-and-down width is called the minor axis. Two distinct fixed points can
be identified on the major axis, called foci and marked F and F, the sum
of whose distances from each point on the ellipse is constant. The distance
across the ellipse at the focal point is called the latus rectum. The
semi-major axis is labeled a, the semi-minor axis b, the half-focal distance
c, and the semi-latus rectum p.
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ovalis, adequate anchoring of the prosthesis on the muscular
septum secundum, symmetrical expansion of the two reten-
tion disks, correct alignment of the device to the atrial
septum, and no interference of the device with neighboring
structures.
Closure protocol and follow-up. Routine examination
before the procedure included electrocardiography (ECG),
chest X-ray, and transthoracic echocardiography. The ASO
deployment was carried out as described elsewhere (2–
4,18), with the only modification that the procedure was
done under ICE guidance alone, without performing
balloon-sizing maneuver and TEE monitoring. The pa-
tients received heparin 70 IU/kg during the procedure,
followed by aspirin for six months; infective endocarditis
prophylaxis was also recommended for the same period.
Before discharge, ECG, chest X-ray and transthoracic
echocardiography were performed and scheduled at 1 and 3
months after device implantation, whereas TEE was per-
formed at 12 months. The residual shunt was classified by
color Doppler echocardiography study, according to criteria
by Boutin et al. (20).
Statistical analysis. Data were expressed as mean value 
SD, and in percentages where appropriate. The SPSS PC
11.0 software package for Windows (SPSS Inc., Chicago,
Illinois) was used for statistical analysis.
RESULTS
Ninety-two ASOs were successfully implanted in 91 pa-
tients during the study period. One of the patients received
two ASOs owing to distant location of multiple holes
within the atrial septum; the largest device was first de-
ployed, and the smaller second device did not overlap the
first.
Adequate quality of ICE images (Figs. 3A and 3B) for
measurements of the semi-major (a) and semi-minor (b)
axes of the fossa ovalis on the two orthogonal planes could
be obtained in all patients (Table 1), with interobserver
variability calculated 3%.
The basic properties of ellipse suggested a roundish
elliptical shape of the fossa ovalis rather than an elongated
one. In fact, the eccentricity was low, the foci half-distance
were approximately one-half of the semi-major axis, and the
semi-latus rectum distance was close to the semi-minor axis.
An excellent correlation was found between the value for
the calculated perimeter and area of the fossa ovalis and the
estimated circumference (y  1.03x  1.42, r2  0.98, p 
0.001, slope  0.94) and area (y  1.05x  17.08, r2 
0.97, p  0.001, slope  0.92) of the ideal circle that
intersects the elliptical fossa ovalis in its semi-latus rectum.
Nevertheless, the perimeter and circumference values
(Online-only Appendix: Equations 4 and 6) had a better
approximation than did those of the area (Online-only
Figure 2. Conceptual circle that best fits an ellipse. An ellipse (red line)
can be constructed by drawing two concentric circles (black lines): the
radius of the inscribed circle defines the semi-minor axis (b), whereas the
radius of the circumscribed circle defines the semi-major axis (a). From c
and p values, the radius (r) of the circle that intersects the ellipse in its
semi-latus rectum (blue line) can be computed.
Figure 3. Transverse section on the aortic valve plane (A), and longitudinal
section on the four-chamber plane (B) in a patient with secundum atrial
septal defect (ASD). The major and minor axes of the fossa ovalis can be
accurately evaluated by intracardiac echocardiography (ICE): a  9.8 mm
and b  9.3 mm. The r value is computed as follows: c 9.82  9.32 
3.090 mm, p 
9.32
9.8
 8.825 mm, r  3.0902  8.8252  9.35 mm,
where c is the foci half-distance, p is the semi-latus rectum distance, and r
is the estimated radius of the ICE-derived Amplatzer Septal Occluder
(ASO). In this case, we implanted a 19-mm ASO. AoD  descending
aorta; LA  left atrium; MV  mitral valve; RA  right atrium; RUPV
 right upper pulmonary vein; TV  tricuspid valve.
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Appendix: Equations 5 and 7) as the area changes much
more than the perimeter, when a circle is the degenerate
case of an ellipse.
Moreover, the ICE-derived radius value of the circle that
intersects the elliptical fossa ovalis in its semi-latus rectum
was used to choose the waist of the ASO, equalling the same
1 mm the 2r value in all cases.
The longitudinal four-chamber plane was capable of
providing clear and easily interpretable images of the entire
procedure, adequately replacing the two-dimensional fea-
tures of TEE (Fig. 4) in all 91 patients. Before and after the
release of the prothesis, the device and surrounding struc-
tures were interrogated by ICE in the two orthogonal
planes. No encroachment of the device occurred on atrio-
ventricular valves, on right pulmonary veins, or on the
superior and inferior caval veins; in addition, complete
coverage of the fossa ovalis and the alignment of the
prosthesis to the septum were assessed in all cases. An
overestimation of the ASO size leading to a bulgy appear-
ance occurred in one patient, but we decided not to replace
the device owing to the satisfactory result.
The procedural times ranged from 34 to 77 min (mean
55.3  21.6 min) and the fluoroscopy times ranged from 5
to 17 min (mean 11.9  6.2 min), and they were not
statistically different from those of our previous series using
TEE. No complications such as device embolization,
thromboembolic events, or pericardial effusion occurred
during the procedure or at the time of follow-up examina-
tions, which ranged from 12 to 28 months (mean 401 days);
in particular, no ICE-related complications occurred. The
rates of complete occlusion were 97.8% (89/91) at 1 year.
During the total follow-up, a small shunt decreased to a
trivial one in one patient, whereas a small shunt appeared at
the three-month follow-up in another patient with initial
complete closure. Subsequent TEE, ICE, and cardiac cath-
eterization confirmed minor displacement of the device with
part of the left retention disk partially protruding to the
right atrium. Notwithstanding, the right ventricular end-
diastolic diameter was decreased, indicating effective abol-
ishment of right heart overload, and the patient did not
undergo surgical removal of the device.
DISCUSSION
Transcatheter closure of ASDs has recently gained wide
acceptance and has become an increasingly attractive alter-
native to surgical repair in selected cases. The unique
features of the ASO have extended the limits of transcath-
eter closure (21–23) with promising short-term and mid-
term results (3,4). However, an extremely precise assessment
of ASDs is crucial for optimal ASO selection and proce-
dural success.
In the absence of a gold standard, the balloon-sizing of
the defect, performed using both the pulling and stationary
techniques, is the most commonly used method to assess
size of ASDs. However, balloon-sizing is far from being
accurate, and this may be associated with certain pitfalls.
First, balloon-sizing, especially if done repeatedly, can itself
cause damage, enlarging the defect by tearing the flap valve
of the septum primum. Second, the estimated stretched
diameter cannot determine the actual dimension of the
defect, and this mainly depends on the force applied in
retrieving the balloon through the defect and on the angle of
balloon popping through the septum. Finally, balloon-
sizing may cause arrhythmias or obstruction of venous
return, although such complications are rare.
In this study, we have seen that ICE allows a proper
measurement of the fossa ovalis and an appropriately sized
device selection, also facilitating all stages of the deployment
process monitoring. The availability of only two-orthogonal
views and of no-color Doppler capability have to be con-
sidered the major disadvantages of the mechanical trans-
Table 1. Measurements
Variable Mean SD Range
On-line ICE measurement
a (mm) 14.5 2.90 6.9–21.3
b (mm) 12.3 2.55 6.5–17.3
Fossa ovalis shape
e (%) 0.476 0.178 0.00–0.790
c (mm) 7.128 3.184 0.00–13.74
p (mm) 10.60 2.83 4.59–15.03
Fossa ovalis size
PFO (mm) 84.5 16.5 43.35–119.70
AFO (mm
2) 578.1 216.7 149.5–1,104.1
ICE-derived measurement
r (mm) 13.22 2.52 6.90–18.55
CASO (mm) 83.0 15.8 43.35–116.49
AASO (mm
2) 567.9 203.1 149.4–1,080.4
ASO waist (mm) 27.1 5.43 14–38
a  semi-major axis; AFO  calculated area of the fossa ovalis; ASO  Amplatzer
Septal Occluder; AASO  estimated area of the ICE-derived ASO; b  semi-minor
axis; c  half-focal distance; CASO  estimated circumference of the ICE-derived
ASO; e  eccentricity of the ellipse; p  semi-latus rectum of the ellipse; PFO 
calculated perimeter of the fossa ovalis; r estimated radius of the circular device; SD
 standard deviation.
Figure 4. Longitudinal section on the four-chamber plane of an implanted
ASO. Note how both disks are clearly visible, thanks to the optimal
echogenicity and the characteristic “multiple ray” pattern of the prosthesis.
The released device acquires a flat shape and covers the entire fossa ovalis.
Abbreviations as in Figure 1.
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ducer in comparison with the electronic one, and the
derivation of quantitative data from geometric assumptions
could be interpreted as the major limitation of our study.
Although recent technologic advances have made it feasible
to use three-dimensional TEE (24,25) and magnetic reso-
nance imaging (26,27) to evaluate ASDs directly, they are
not currently or readily available for online clinical use in the
catheterization laboratory. Moreover, it is our opinion that
color-flow Doppler capability is not strictly necessary. On
the one hand, immediate residual shunt is demonstrated on
TEE in the vast majority of cases, and complete occlusion of
the defect can require hours, days, or even months (3,28–
31). On the other hand, by selecting ASO based on the
fossa ovalis measurement and not on the defective area, it
ensures stable anchoring of the device into the muscular
septum secundum, thus reducing the possibility of peripros-
thetic leaks.
Previous experiences have confirmed that ICE is an
extremely useful method to evaluate ASDs in patients
undergoing transcatheter closure by an ASO, and have also
provided the basic accuracy of the technique (16,17). The
current study adds a new and quantitative use for ICE
imaging with several clinical implications. First, it proposes
two standardized planes for accurate measurements of the
major and minor axes of the fossa ovalis. Second, it defines
a calculation process, also available in a simple software
program, for the selection of an ASO device, thus eliminat-
ing the cumbersome balloon-sizing maneuver. Third, it
identifies the ICE four-chamber section as a view that can
replace TEE monitoring during the procedure, thus abol-
ishing the need for general anesthesia or sedation, without
additional patient discomfort. Fourth, ICE imaging estab-
lishes the safety and feasibility of using ICE alone as an
adjunct to fluoroscopy and as the primary means of trans-
catheter closure of ASDs: with this approach, patient
acceptance of the procedure increases, and the results are
comparable to those reported by use of the conventional
methods. Fifth, our mathematical model supports the ac-
curacy of ICE-derived fossa ovalis evaluation, suggesting to
proceed with the transcatheter closure of ASDs only in case
of roundish elliptical fossa ovalis so as to avoid improper
deformation of the circular waist of the ASO when it is
stretched into the minor axis of the fossa ovalis (“mush-
rooming” appearance) and to prevent periprosthetic leaks,
which may occur across its major axis if the fossa ovalis has
an elongated shape. Finally, for the successful closure of an
ASD on ICE guidance alone, the unique self-centering
ability of the ASO is fundamental, and this strategy is not
suitable for other devices.
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APPENDIX
For the Appendix, please see the November 5, 2003 issue of
JACC at http://www.cardiosource.com/jacc.html.
1682 Zanchetta et al. JACC Vol. 42, No. 9, 2003
ICE-Guided Transcatheter Closure November 5, 2003:1677–82
